Comparison of GAD and ICA512/IA-2 antibodies at and after the onset of IDDM

Diabetes Care

Volumn 21, Issue 1, 1998, Pages 49-52

  Yokota, Ichiro ^a,b   Matsuda, Junko ^a   Naito, Etsuo ^a   Ito, Michinori ^a   Shima, Kenji ^a   Kuroda, Yasuhiro ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY GAD; MONOCLONAL ANTIBODY ICA512; THYROID ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; ONSET AGE; PREVALENCE; THYROID GLAND;

EID: 2642705884     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.1.49     Document Type: Article

References (20)

1. Eisenbarth GS, Ziegler A, Colman P: Pathogenesis of insulin-dependent (type 1) diabetes mellitus. In Joslin's Diabetes Mellitus. Kahn CR, Weir GC, Eds. Philadelphia, Lea & Febiger, 1994, p. 216-239
2. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena MS, Cascalho M, Folli F, Richter-Olesen H, DeCamilli P: Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347:151-156, 1990
3. Lan MS, Lu J, Goto Y, Notkins AL: Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol 13:505-514, 1994
4. Rabin DU, Pleasic SM, Shapiro JA, Yoo-Warren H, Oles J, Hicks JM, Goldstein DE, Rae PMM: Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J Immunol 152:3183-3188, 1994
5. Christie MR, Genovese S, Cassidy D, Bosi E, Brown TJ, Lai M, Bonifacio E, Botazzo GF: Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity. Diabetes 43:1254-1259, 1994
6. Myers MA, Rabin DU, Rowley MJ: Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase. Diabetes 44:1290-1295, 1995
7. Gianani R, Rabin DU, Verge CF, Yu L, Babu SR, Pietropaolo M, Eisenbarth GS: ICA512 autoantibody radioassay. Diabetes 44:1340-1344, 1995
8. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth GS: Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/ IA-2 autoantibodies. Diabetes 45:926-933, 1996
9. Roll U, Christie MR, Füchtenbusch M, Payton M, Hawkes CJ, Ziegler A-G: Perinatal autoimmunity in offspring of diabetic parents: the German multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood. Diabetes 45:967-973, 1996
10. Genovese S, Bonfanti R, Bazzigaluppi E, Lampasons V, Benazzi E, Bosi E, Chiumello G, Bonifacio E: Association of IA-2 autoantibodies with HLA DR4 phenotypes in IDDM. Diabetologia 39:1223-1226, 1996
11. Kawasaki E, Eisenbarth GS, Wasmeier C, Hutton JC: Autoantibodies to protein tyrosine phosphatase-like protein in type 1 diabetes: overlapping specificities to phogrin and ICA512/IA-2. Diabetes 45:1344-1349, 1996
12. Bonifacio E, Genovese S, Braghi S, Bazzigaluppi E, Lampasona V, Bingley PJ, Rogge L, Pastore MR, Bognetti E, Bottazzo GF, Gale EAM, Bosi E: Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity. Diabetologia 38:816-822, 1995
13. Verge CF, Howard NJ, Rowley MJ, Mackay IR, Zimmer PZ, Egan M, Hulinska H, Hulinsky I, Silvestrini RA, Kamath S, Sharp A, Arundel T, Silink M: Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study. Diabetologia 37:1113-1120, 1994
14. Ziegler AG, Standl E, Albert E, Mehnert H: HLA-associated insulin autoantibody formation in newly diagnosed type 1 diabetic patients. Diabetes 40:1146-1149, 1991
15. Mimura G, Kida K, Matsuura N, Toyota T, Kitagawa T, Kobayashi T, Hibi I, Ikeda Y, Tuchida I, Kuzuya H, Aono S, Doi K, Nishimukai H, Jinnouchi T, Murakami K: Immunogenetics of early-onset insulin-dependent diabetes mellitus among the Japanese: HLA, Gm, BF, GLO, and organ-specific autoantibodies: the J.D.S. study. Diabet Res Clin Pract 8:253-262, 1990
16. Kawasaki E, Takino H, Yano M, Uotani S, Matsumoto K, Takao Y, Yamaguchi Y, Akazawa S, Nagataki S: Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Diabetes 43:80-86, 1994
17. Christie MR, Brown TJ, Cassidy D: Binding of antibodies in sera from type 1 (insulin-dependent) diabetic patients to glutamate decarboxylase from rat tissues: evidence for antigenic and non-antigenic forms of the enzyme. Diabetologia 35:380-384, 1992
18. Hallengren B, Falorni A, Landin-Olsson M, Lernmark Å, Papadopoulos KI, Sundkvist G: Islet cell and glutamic acid decarboxylase antibodies in hyperthyroid patients: at diagnosis and following treatment. J Intern Med 239:63-68, 1996
19. Björk E, Velloso LA, Kämpe O, Karlsson FA: GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type 1 recognize different epitopes. Diabetes 43:161-165, 1994
20. Daw K, Ujihara N, Atkinson M, Powers AC: Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition. J Immunol 156:818-825, 1996